Pomerantz LLP is investigating Omeros Corporation for possible securities fraud after the company’s stock price dropped significantly following two negative opinions from the European Medicines Agency (EMA) on its drug narsoplimab. The EMA’s Committee for Medicinal Products for Human Use (CHMP) rejected Omeros’s marketing authorization application for treating TA-TMA in June and again after re-examination in October 2026. These rejections caused Omeros’s stock to fall sharply, prompting the investigation into whether the company or its executives engaged in unlawful practices. Investors affected are encouraged to contact Pomerantz LLP for potential class action participation.
Regarding Omeros Corporation, here is Pluang's market snapshot as of Nov 04, 2026 05:12 WIB: Among 150 priced Health-sector US stocks tradable on Pluang, 89 rose and 58 fell today. Notable movers include NBIX at USD 163.75 with a 1-day change of +12.66% and a typical hold time of 26 days, INO at USD 1.67 down -11.90% with a 41-day hold time, and IOVA at USD 8.86 up +10.47% with a 4-day hold time. Pluang order activity shows a strong sell bias for NBIX and IOVA, but a more balanced sell/buy split for INO.
Nova Klúbburinn hf. has completed a share buyback program, acquiring 122,699,386 shares at an average price of ISK 3.26 per share. The buyback was part of an inverse offer process with valid bids for 159,526,476 shares. The company accepted bids up t...
FerdiS monitors dividend changes across 1,200+ stocks, highlighting strong dividend increases from Visa (V), Ameriprise Financial (APH), and Hartford Financial (HIG) due to their robust growth and safety metrics. Energy companies ExxonMobil (XOM) and...
Polygon Chain, a layer-2 network built to enhance Ethereum's speed and reduce costs, reportedly processed more transactions than the global population, according to crypto commentator @0xPolygon. While the exact transaction count and timeframe were n...
World Liberty Financial (WLFI) saw its price fall 8.02% within one hour on Binance, dropping from $0.0511 to $0.047 on Nov. 3. Over 24 hours, WLFI was down 6%, reflecting broader selling pressure. During the same hour, long position liquidations tota...
West Coast Community Bancorp reported strong third-quarter 2026 results, showing a 20% increase in earnings year-over-year for the first nine months. Despite robust operational performance and a 16% dividend increase for Q4 2026, the bank's valuation...
